DELAYED ELIMINATION OF ENOXAPARINE IN PATIENTS WITH CHRONIC RENAL-INSUFFICIENCY

被引：140
作者：
CADROY, Y
POURRAT, J
BALADRE, MF
SAIVIN, S
HOUIN, G
MONTASTRUC, JL
VERNIER, I
BONEU, B
机构：
[1] CHU TOULOUSE,SERV PHARMACOL MED & CLIN,INSERM,U317,F-31073 TOULOUSE,FRANCE
[2] HOP PURPAN,UNITE PHARMACOCINET,F-31059 TOULOUSE,FRANCE
[3] HOP PURPAN,SERV NEPHROL,F-31059 TOULOUSE,FRANCE
[4] FAC MED TOULOUSE,F-31073 TOULOUSE,FRANCE
来源：
THROMBOSIS RESEARCH | 1991年 / 63卷 / 03期
关键词：
LOW MOLECULAR WEIGHT HEPARIN; PHARMACOKINETICS; CHRONIC RENAL FAILURE;
D O I：
10.1016/0049-3848(91)90141-I
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：385 / 390
页数：6
相关论文
共 10 条
[1]  
Boneu B, 1990, Baillieres Clin Haematol, V3, P531, DOI 10.1016/S0950-3536(05)80017-4
[2]  
BONEU B, 1989, THROMB HAEMOSTASIS, V62, P524
[3]  
BRIANT L, 1989, THROMB HAEMOSTASIS, V61, P348
[4]   DISAPPEARANCE OF CIRCULATING ANTI-XA ACTIVITY AFTER INTRAVENOUS-INJECTION OF STANDARD HEPARIN AND OF A LOW-MOLECULAR WEIGHT HEPARIN (CY-216) IN NORMAL AND NEPHRECTOMIZED RABBITS [J].
CARANOBE, C ;
BARRET, A ;
GABAIG, AM ;
DUPOUY, D ;
SIE, P ;
BONEU, B .
THROMBOSIS RESEARCH, 1985, 40 (01) :129-133
[5]  
FOLLEA G, 1986, HAEMOSTASIS, V16, P147
[6]   THE ANTITHROMBOTIC ACTIVITY AND PHARMACOKINETICS OF ENOXAPARINE, A LOW-MOLECULAR WEIGHT HEPARIN, IN HUMANS GIVEN SINGLE SUBCUTANEOUS DOSES OF 20 TO 80 MG [J].
FRYDMAN, AM ;
BARA, L ;
LEROUX, Y ;
WOLER, M ;
CHAULIAC, F ;
SAMAMA, MM .
JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (07) :609-618
[7]   LOW-MOLECULAR-WEIGHT HEPARIN HALF-LIFE IS PROLONGED IN HEMODIALYZED PATIENTS [J].
GOUDABLE, C ;
THAT, HT ;
DAMANI, A ;
DURAND, D ;
CARANOBE, C ;
SIE, P ;
BONEU, B .
THROMBOSIS RESEARCH, 1986, 43 (01) :1-5
[8]  
KAMPMANN J, 1974, ACTA MED SCAND, V196, P517
[9]  
PALM M, 1987, THROMB HAEMOSTASIS, V58, P932
[10]   HEPARIN PHARMACOKINETICS - INCREASED REQUIREMENTS IN PULMONARY-EMBOLISM [J].
SIMON, TL ;
HYERS, TM ;
GASTON, JP ;
HARKER, LA .
BRITISH JOURNAL OF HAEMATOLOGY, 1978, 39 (01) :111-120
1